Dexamethasone intravitreal implant
Term · Oncology and biomedicine · MLC-T-ONC-013007
An intravitreal implant containing the corticosteroid dexamethasone embedded in a biodegradable polymer matrix, with anti-inflammatory and macular edema-relieving activity. Upon insertion into the vitreous cavity, dexamethasone intravitreal implant is dissolved slowly and dexamethasone is released over an extended period of time. Dexamethasone inhibits inflammation thereby preventing leakage from the capillaries and a reduction of retinal edema. This may ultimately prevent vision impairment.
| Identifier | MLC-T-ONC-013007 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013007",
"term": "Dexamethasone intravitreal implant",
"field": "Oncology and biomedicine",
"definition": "An intravitreal implant containing the corticosteroid dexamethasone embedded in a biodegradable polymer matrix, with anti-inflammatory and macular edema-relieving activity. Upon insertion into the vitreous cavity, dexamethasone intravitreal implant is dissolved slowly and dexamethasone is released over an extended period of time. Dexamethasone inhibits inflammation thereby preventing leakage from the capillaries and a reduction of retinal edema. This may ultimately prevent vision impairment.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/dexamethasone-intravitreal-implant/"
}
Record 5,890 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.